OHSU
Return to Listing

3 result(s) for Endocrine Cancers

PI Name Protocol # Title
Kresimira Milas IRB00009420 Oregon Index of Endocrine Neoplasias (ORION)
Matthew Taylor IRB00009480 A Randomized, Double Blind Study to Compare the Complete Remission Rate Following a 5-Week Course of Selumetinib or Placebo and Single Dose Adjuvant Radioactive Iodine Therapy in Patients with Differentiated Thyroid Cancer
Matthew Taylor IRB00010987 E7080-G000-398: An Open-Label, Randomized, Multicenter, Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080
 

You may qualify for additional trials within our Phase 1 Program